share_log

HCA Healthcare | 8-K: HCA Healthcare reports THIRD quarter 2024 results

HCA Healthcare | 8-K: HCA Healthcare reports THIRD quarter 2024 results

HCA醫療 | 8-K:HCA Healthcare公佈2024年第三季度業績
美股SEC公告 ·  2024/10/25 07:42

Moomoo AI 已提取核心訊息

HCA Healthcare reported Q3 2024 revenues of $17.487 billion, with net income reaching $1.270 billion or $4.88 per diluted share. Same facility admissions increased 4.5%, while emergency room visits rose 4.6% compared to Q3 2023. The results include a $0.15 per share impact from Hurricane Helene.The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts. Hurricane-related expenses and revenue losses are estimated at $200-300 million for Q4 2024. Operating cash flows strengthened to $3.515 billion, up from $2.479 billion in Q3 2023.The Board declared a quarterly cash dividend of $0.66 per share, payable on December 27, 2024, to stockholders of record on December 13, 2024. During Q3, the company repurchased 4.948 million shares for $1.795 billion, with $2.433 billion remaining under its repurchase authorization.
HCA Healthcare reported Q3 2024 revenues of $17.487 billion, with net income reaching $1.270 billion or $4.88 per diluted share. Same facility admissions increased 4.5%, while emergency room visits rose 4.6% compared to Q3 2023. The results include a $0.15 per share impact from Hurricane Helene.The company maintained its 2024 guidance but expects results in the lower half of the range due to hurricane impacts. Hurricane-related expenses and revenue losses are estimated at $200-300 million for Q4 2024. Operating cash flows strengthened to $3.515 billion, up from $2.479 billion in Q3 2023.The Board declared a quarterly cash dividend of $0.66 per share, payable on December 27, 2024, to stockholders of record on December 13, 2024. During Q3, the company repurchased 4.948 million shares for $1.795 billion, with $2.433 billion remaining under its repurchase authorization.
HCA醫療報告2024年第三季度營業收入爲174.87億美金,凈利潤達到12.7億美金,每股稀釋後收益爲4.88美金。相同設施的入院人數增加了4.5%,而急診室的就診人數較2023年第三季度上升了4.6%。結果包括來自颶風海倫每股0.15美金的影響。該公司保持了2024年的指導預測,但由於颶風的影響,預計結果將在區間的下半部分。與颶風相關的費用和收入損失預計在20000-30000萬美金之間,適用於2024年第四季度。營運現金流增強至35.15億美金,而2023年第三季度爲24.79億美金。董事會宣佈每股現金股息爲0.66美金,將於2024年12月27日向2024年12月13日的登記股東支付。在第三季度,該公司回購了494.8萬股股份,耗資17.95億美金,回購授權下還有24.33億美金的餘額。
HCA醫療報告2024年第三季度營業收入爲174.87億美金,凈利潤達到12.7億美金,每股稀釋後收益爲4.88美金。相同設施的入院人數增加了4.5%,而急診室的就診人數較2023年第三季度上升了4.6%。結果包括來自颶風海倫每股0.15美金的影響。該公司保持了2024年的指導預測,但由於颶風的影響,預計結果將在區間的下半部分。與颶風相關的費用和收入損失預計在20000-30000萬美金之間,適用於2024年第四季度。營運現金流增強至35.15億美金,而2023年第三季度爲24.79億美金。董事會宣佈每股現金股息爲0.66美金,將於2024年12月27日向2024年12月13日的登記股東支付。在第三季度,該公司回購了494.8萬股股份,耗資17.95億美金,回購授權下還有24.33億美金的餘額。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息